By: Guo-Qi Li, Zhe Wang, Tong Zhao, Shi-Xuan Dai, Jia-Ming Liu,
Bo-Zhi Jia, Yi Zhang, and Qian Li. Journal of Hypertension. 36(4):801–808, APR 2018.
One feature that describes obesity is hypertension, which is caused by an increased sympathetic nervous system. More specifically, the activity of the rostral ventrolateral medulla (RVLM) is increased. The RVLM plays an important role in regulating sympathetic activity. This region has been seen to contribute to the obesity-induced hypertension. This study focuses on the cannabinoid type 1 (CB1) receptor in the RVLM which has been shown to increase activity in the sympathetic nervous system when there is high expression. They hypothesized that CB1 receptor plays a critical role in the development of obesity induced hypertension. To test this, two major endocannabinoids were evaluated, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), for expression in the RVLM, then examined for their role in regulation of BP, HR, and renal sympathetic activity (RSNA).
Microinjections were performed on the rats (4-6 weeks old). One group received unilateral RVLM injections of saline and 100nM/0.5ul AM251 (a selective cannabinoid CB1 receptor antagonist). The second group received unilateral RVLM injection of saline and 500nM/0.5ul AM251. BP, HR, and RSNA were monitored for 1 h followed by a second microinjection after 30 min. Western blotting was used to examine CB1 receptor protein levels in RVLM. To examine levels of AEA and 2-AG, separate groups of rats were used for quantification. Following the experiments, rats were euthanized and the brains were sectioned.
The results showed that rats with a high fat diet were found to have an increased BP, HR, and basal RSNA. As for the CB1 receptor, it was found that the levels of the two endocannabinoids was enhanced in high fat diet (HFD) rats. The protein level was also enhanced.
The role of CB1 in the RVLM was shown to have increased levels. The RVLM microinjections of AM251 showed decreased BP, HR, and RSNA in HFD rats, which suggest that CB1 receptor mediated neurotransmission might be increased in RVLM in the HFD rats. Previous studies have shown that an expression of CB1 receptor in the RVLM is higher in hypertensive rats. CB1 receptor antagonists lowered BP much more in hypertensive rats, which explains the importance of these receptors to the contributions to BP regulation.
This study drew interest from myself due to the important contribution of cannabinoid receptor in the RVLM. I had no idea this type of receptor existed in the RVLM, which goes to show how many different inputs the RVLM receives and converts into an output on sympathetic activity.
-Tsetse Fly
Monday, October 15, 2018
Friday, October 12, 2018
Comparison of four methods of averaging nerve activity
Francis A. Hopp, Jeanne L. Seagard, John P. Kampine
Am J Physiol (1986)
Changes in nerve activity is used to monitor the response of a physiological system. Measuring nerve activity has been accomplished using many different methods, depending on what is being researched. Some methods focus on how nerve activity is related to total number of active fibers or some relate nerve activity to total voltage. At the time of this paper it was not determined if any method of analysis was better than others. The most common are counting spikes (Spikes), measuring the moving time average (analog), integrating the neural signal (Integrated), and processing activity using a voltage-to-frequency converter (VFC). This paper compares characteristics of these four averaging techniques.
Mongrel dogs were anesthetized and maintained using a fusion pump. The nerve activity was recorded from carotid sinus nerve, the cervical vagus, and a renal nerve. The data was analyzed by processing the activity using the four types of averaging systems. Pulse trains were used to verify the linearity of each averaging method with respect to changes in frequency, amplitude, and width. Analysis was also done by performing regressions on the average outputs of each method against the other methods for the same input.
When measuring the moving time average, full wave rectified nerve activity was processed using a low-pass filter that smoothed spikes into a time-varying voltage level with an instantaneous amplitude proportional to the total voltage of the electroneurogram per averaging interval. In the VFC averaging method, nerve activity was full wave rectified and processed through a VFC with a gain of 10kHz/V. The output frequency of the VFC was proportional to the instantaneous value of the total voltage of the electroneurogram. VFC pulses were then counted in 100 ms intervals which generated a stair-step voltage proportional to the average activity for the previous interval. Using the integration method, nerve activity was full wave rectified and integrated. The integrator was reset ever 100 ms. The result was a signal processed using a peak detector to generate a stair-step proportional to the total integrated nerve activity per unit time for the previous interval. In the counting spikes method, a multiplexing circuit was used to display both the neural signal voltage threshold on a single oscilloscope channel. The threshold was set by eye to a level just above the noise. Each neural spike above the set threshold was then counted.
The study showed that all averaging methods are linear with respect to frequency modulated pulse trains. Analog, integrated , and VFC are linear with respect to width and amplitude, but spikes responses in a nonlinear way to amplitude modulation and does not respond to pulse width modulation. Analog, integrated, and VFC are able to average pulse summations, while spike output in reduced. This shows that counting spikes should be used for a preparation with fewer nerve fibers.
Although this paper is from 1986, analyzing nerve activity today is not extremely different. The ability to pick out individual axon’s activity from raw bulk records has still evaded researchers, but science is getting very close. This study of four methods helps me further understand the process I am currently working on in lab by showing limitations of older methods and by forcing the reader to think of how new methods must be designed to sharpen the results.
-Paul M (My childhood nickname was Bambi)
Monday, October 8, 2018
IMPAIRED BLOOD PRESSURE COMPENSATION FOLLOWING HEMORRHAGE IN CONSCIOUS OBESE ZUCKER RATS
By: Lusha Xiang, John S. Clemmer, Silu Lu, and Peter N. Mittwede. Life Sci. 2013 August 14; 93(0): 214–219.
Hemorrhage shock has been linked to a higher risk for mortality and morbidity in obese patients. Blood loss can lead to things like organ failure and increased inflammatory response. The most important factor is that because of this blood loss, volume is decreased. When volume is decreased, blood pressure (BP) follows suit. When hypovolemia occurs, sympathetic nerve activity (SNA) is increased, as well as the release of vasoconstrictors like angiotensin II and antidiuretic hormone (ADH). The purpose of these actions is to increase total peripheral resistance (TPR), in order to bring BP back up. The study focuses on obese patients exclusively since no other studies have been done relating obesity and severe hemorrhage.
This study focused on how well (or poorly) the obese rats are able to recover BP following a severe hemorrhage. Their previous studies showed that BP recovery is significantly impaired following a hemorrhage under anesthesia. This study will focus on conscious obese zucker rats (OZ), compared to lean Zucker rats (LZ). They hypothesized that BP compensation following a severe hemorrhage is impaired in conscious OZ.
The mean body weight for LZ was 306g. The mean body weight for OZ was 452g. Rats were anesthetized and catheters were inserted to record BP and heart rate (HR) before and after hemorrhage. Baroreflex sensitivity and basal sympathetic tone were also measured. Hemorrhage was induced by withdrawing 35% of total blood volume from the femoral catheter (0.5 mL/min, 6-8 ml). BP and heart rate was measured during and 1 hour following the hemorrhage.
The following results were observed:
Baroreflex sensitivity and basal sympathetic tone
Hemorrhage shock has been linked to a higher risk for mortality and morbidity in obese patients. Blood loss can lead to things like organ failure and increased inflammatory response. The most important factor is that because of this blood loss, volume is decreased. When volume is decreased, blood pressure (BP) follows suit. When hypovolemia occurs, sympathetic nerve activity (SNA) is increased, as well as the release of vasoconstrictors like angiotensin II and antidiuretic hormone (ADH). The purpose of these actions is to increase total peripheral resistance (TPR), in order to bring BP back up. The study focuses on obese patients exclusively since no other studies have been done relating obesity and severe hemorrhage.
This study focused on how well (or poorly) the obese rats are able to recover BP following a severe hemorrhage. Their previous studies showed that BP recovery is significantly impaired following a hemorrhage under anesthesia. This study will focus on conscious obese zucker rats (OZ), compared to lean Zucker rats (LZ). They hypothesized that BP compensation following a severe hemorrhage is impaired in conscious OZ.
The mean body weight for LZ was 306g. The mean body weight for OZ was 452g. Rats were anesthetized and catheters were inserted to record BP and heart rate (HR) before and after hemorrhage. Baroreflex sensitivity and basal sympathetic tone were also measured. Hemorrhage was induced by withdrawing 35% of total blood volume from the femoral catheter (0.5 mL/min, 6-8 ml). BP and heart rate was measured during and 1 hour following the hemorrhage.
The following results were observed:
Baroreflex sensitivity and basal sympathetic tone
- Basal BP and heart rate did not differ between LZ and OZ
- HR was blunted in OZ in response to dose of sodium nitroprusside (SNP)
- OZ showed a greater decrease in basal BP when prazosin was injected
Responses to hemorrhage
- Basal BP was not different between LZ and OZ.
- Hemorrhage dropped BP in both groups and was not different between LZ and OZ immediately after hemorrhage.
- At 30 and 60 min of recovery, OZ had significantly lower BP.
- Basel HR was higher in OZ.
- LZ HR decreased immediately after hemorrhage, but increased and stayed up thereafter.
- OZ had decreased HR throughout recovery period and was lowered than LZ.
- Oxygen consumption dropped in both groups following hemorrhage, OZ significantly lower.
- Cardiac output dropped in similar levels in both groups
- TPR, plasma renin activity (PRA), and ADH increased in both groups, but the increases were significantly lower in OZ
The results of the experiment have told us that OZ exhibited a blunted baroreflex sensitivity and elevated basal sympathetic tone compared to LZ. Following hemorrhage, OZ had an impaired increase of TPR, PRA, and ADH, as well as blunted recovery of BP. It is pretty clear that the ability to recover from a severe hemorrhage is more difficult in the obese group. The blunted baroreflex sensitivity explains why in OZ, they could not recover as well. The baroreflex is very important in controlling BP on a beat to beat basis. The mechanism to why this is happening is unknown.
The reason why I chose this paper was instead of studying obesity, we want to study sedentary conditions. The same type of study could be done in our lab, except we would be comparing seds to runners!
-Tsetse Fly
Friday, October 5, 2018
Estrogen receptor-beta (ERb) in the PVN and RVLM plays an essential protective role in aldosterone/salt-induced hypertension in female rats
By Baojian Xue, Zhongming Zhang, Terry G Beltz, Ralph F Johnson, Fang Guo, Meredith Hay, and Alan Kim Johnson.
Journal of Hypertension, June 2013.
Estrogen receptors alpha and beta (ERa and ERb, respectively) are expressed in many nuclei involved in the control of the sympathetic nervous system. Interestingly, the action of estrogen on ERb attenuates glutamate-induced increases in blood pressure in the RVLM. Furthermore, estrogen attenuated Aldosterone (Aldo)-induced hypertension in both males and OVX females. However, it has previously been shown that certain brain areas have a predominant expression of a certain subtype. For example, ERa predominates in the NTS and ERb is predominant in the PVN. The purpose of this study was to investigate the role of ER subtypes in the PVN and RVLM and to measure the protective effects estrogen has on the development of Aldo-induced hypertension in those areas.
10-12 week old female rats were used. There were 12 different groups: Intracerebroventricular (icv) infusions of a vehicle, ERb agonist diarylpropionitrile (DPN), or ERa agonist propyl-pyrazole-triol (PPT) in OVX females; icv injections of adeno-associated virus (AAV) carrying siRNA-SCM (small interfering RNA injected to create a “control” group that did not have any receptors silenced), AAV-siRNA-ERa (to silence ERa), and AAV-siRNA-ERb (to silence ERb) into intact females; PVN microinjections of siRNA-ERb, -ERa, or 1SCM into intact females; and RVLM microinjections into intact females using the same siRNA types. All animals received subcutaneous injections of Aldo and 1% NaCl as their drinking water. Reactive oxygen species studies were also completed. Cultured PVN neurons were incubated in either: (1) siRNA-SCM and vehicle (control group); (2) siRNA-SCM and Aldo (the hypertension group); (3) siRNA-ERa and Aldo and; (4) siRNA-ERb and Aldo.
After 21 days of Aldo/NaCl treatment, the female OVX rats had an average of 21.1 mmHg increase in MAP. Upon PPT and DPN icv infusions for 21 days, the rats had a significant attenuation of Aldo-induced hypertension. Furthermore, when given icv injections of either siRNA-ERa or siRNA-ERb, OVX females had further increases in the MAP. Thus, both ER agonists showed protective effects when circulating throughout the entire brain.
Individual areas of the brain involved in sympathetic nervous system control were investigated to further understand the roles of the different ER subtypes. Microinjections of siRNA-SCM into the PVN produced slight increases in MAP. SiRNA-ERb microinjections into the PVN resulted in a significant average increase of 16.1 mmHg. However, siRNA-ERa only resulted in an average increase of 11.2 that was not significantly different from siRNA-SCM injections. Thus, the researchers believe this helps support the notion that ERb is the predominant receptor in the PVN that helps attenuate Aldo-induced hypertension. Similar results were shown with the microinjections into the RVLM—the siRNA-ERb, and not siRNA-ERa, produced significant increases in MAP when compared to siRNA-SCM.
Hexamethonium (hex) was injected after in OVX females after 21 days of Aldo infusion to further examine effects of the region-specific ER subtypes. Hex caused greater reductions in blood pressure in OVX females compared to those who received icv DPN or PPT. Thus, rats with no circulating estrogen had higher blood pressure compared to those who had circulating estrogen and ER agonist. Furthermore, intact rats who were also treated with siRNA-ERb via icv, PVN, or RVLM microinjections resulted in greater drops of blood pressure when given hex. siRNA-ERa and hex showed no difference in blood change for intact females compared to those with siRNA-SCM and hex injections. These results suggested that ERb is the primary ER subtype that attenuates blood pressure in Aldo-induced hypertensive rats.
AAV knockdown occurred in animals to verify that the siRNA injections was indeed silencing the receptors. AAV-siRNA-ERa and -ERb contained green fluorescent protein (GFP) to verify that the receptors were silenced after injections. If the receptors were silenced, they would express GFR and glow. Micropunches were taken of either the RVLM or PVN, depending on the injection site, to collect samples. These samples confirmed that the receptors were silenced and that the siRNA was contained within the selected brain region. The levels of both receptor types were reduced by 44 to 74% when compared to injections with siRNA-SCM.
Lastly, the ROS levels were measured and compared in the siRNA-ERa and siRNA-ERb intact females after the collected PVN neurons were treated with Aldo overnight. When either receptor was silenced, there was an enhanced Aldo-induced increase in ROS production. Thus, the researchers suggest that Aldo increases sympathetic nerve activity and estrogen works to inhibit those effects. By silencing the receptors, the hypertensive effects become attenuated as the neurons become more active.
Overall, the study showed that both ERa and ERb have protective roles against the development of Aldo-induced hypertension in female rats. Without active ERb in the RVLM or PVN, hypertension is augmented, while silenced ERa showed little effect. Thus, the distribution of ER is region-specific to provide protective protective properties against Aldo-induced hypertension. However, this may be true only for Aldo-induced hypertension. Other studies have suggested that ERa is more active depending on the model of hypertension, and ERb is key for all types of hypertension. More studies need to be done in order to better understand the role of the specific receptors in the different brain areas that control sympathetic nerve outflow and thus blood pressure.
-LivInLaVida
Spontaneously hypertensive rats exhibit higher sensitivity to ethanol-induced hypotensive effects: Role of NMDA receptors and nitric oxide in rostral ventrolateral medulla
Lin HH, Cheng TT, Lo H, Lin YC, Lai CC.
Alcohol (2018)
Intake of ethanol (alcohol) can effect many physiological functions, including cardiovascular function. Ingestion of large amounts of ethanol can cause tachycardia, vasodilation, and hypotension in humans. Glutamate and GABA receptors in the central nervous system are the targets of ethanol. These two neurotransmitters regulate the pre-sympathetic nerves in the rostral ventrolateral medulla (RVLM). Nitric oxide is also a molecule used to send messages and ethanol effects its production through the enzymes producing it, nitric oxide synthase (NOS). This study shows that ethanol acting on glutamatergic NMDA receptors and nitric oxide signaling in the RVLM plays an important role in its hypotensive effects.
The rat microinjections of nitric oxide synthase (NOS) inhibitors or NMDA receptor blockers was done by injecting a micropipette with micosyringes into the left and right RVLM. The first injections were given to conscious rats. SHRs exhibited a significantly higher blood pressure compared to the normotensive wild type rats. An injection of a lower dose of ethanol produced a decrease in systolic blood pressure (SBP) and diastolic blood pressure (DBP) in spontaneously hypertensive rats (SHRs), but did not produce any differences in normotensive rats, or wild type. The decrease in BP continues for 30 minutes after the injection and the effects lasted over 90 minutes in the SHRs. When a higher dose of ethanol was injected, even more decreases in SBP and DBP was shown in both wild type and SHRs.
The second group to receive injections were under urethane anesthesia. The lower dose of ethanol caused a decrease in SBP about 60 minutes after injection in SHRs, but did not exhibit significant changes in DBP for SHRs. The wild type rats did not show a significant change in BP when given the lower dose. The higher dose of ethanol did result in significant decreases in BP in both wild type and SHRs, although the decrease occurred much earlier in SHRs. These deceased effects occurred both early around 15 minutes and late around 45-60 minutes after the injection in wild type and SHRs.
Microinjections of L-NNA, which is a competitive NOS inhibitor, into the RVLM showed no significant changes in BP 15-60 minutes after injection in wild type and SHRs. A small dose of L-NNA injected into the RVLM 5 minutes after ethanol showed no significant effects on BP, but a higher dose significantly reduced the ethanol induced decreased in SHRs but not wild type. Ethanol induced decreases in SBP and DBP in SHRs were also blocked when the RVLM was given a NOS inhibitor or NMDA receptor antagonists. Microdialysis was then used to determine how much nitric oxide is released. This was done by measuring the amount of nitrite and glutamate in the RVLM after an injection of ethanol in wild type and SHRs. The ethanol caused a significant increase in nitrite and glutamate released in SHRs, but no significant change in wild types.
This study showed that SHRs have a high sensitivity to ethanol induced hypotensive effects and suggests that the NMDA receptors and nitric oxide system is the mechanism in the RVLM that is involved. The researchers did mention possible problems with their experiment, one being how anesthetics do affect blood pressure. It was also mentioned that since ethanol is widely distributed throughout the body after application, it may have effects on other cardiovascular mechanisms.
Paul M
Tuesday, October 2, 2018
Estrogen Replacement
Reduces Oxidative Stress in the Rostral Ventrolateral Medulla of Ovariectomized
Rats
Fan Hao et. al.
Oxidative Medicine
and Cellular Longevity
It is
well known that the incidence of cardiovascular disease increases in women
after they go through menopause. The reasons behind this effect are unclear,
but it is thought that the hormones that are circulating in the blood prior to
menopause have some sort of protective effect against cardiovascular disease. Specifically,
estrogen has been shown to modulate activity in the central nervous system. It is
well known that the Rostral Ventrolateral Medulla (RVLM) is a key regulator of sympathetic
outflow for the cardiovascular system. It has been shown that over activity of
the RVLM is implicated in cardiovascular disease and that there is higher sympathetic
outflow in ovariectomized rats. This suggests that the ovarian hormones may be
playing a role in decreasing sympathetic outflow and thus the incidence of cardiovascular
disease in pre-menopausal women. Increased oxidative stress due to reactive
oxygen species have been implicated in development of hypertension. Oxidative
stress is primarily due to an imbalance of the formation and removal of
reactive oxygen species. NADPH oxidase will form a superoxide and superoxide
dismutase will catalyze the breakdown of the superoxide to oxygen or hydrogen
peroxide. Thus, a measurement of the relative activity of NADPH oxidase and
superoxide dismutase provides a measurement of oxidative stress. Oxidative
stress in the RVLM has been associated with increased sympathetic outflow and hypertension.
The aim of the present study was to assess the level of oxidative stress in the
RVLM of ovariectomized rats with and without estrogen replacement.
Sprague-Dawley
rats were assigned to one of four groups: ovariectomy with estrogen, ovariectomy
with vehicle, sham with estrogen and sham with vehicle. Sham groups had the
same operation as the ovariectomy group but did not have the ovaries removed. One
week after the procedure the estrogen groups were treated with 17-beta-estradiol
for four weeks via subcutaneous injections. The vehicle groups had the same
injections but with 0.9% normal saline. Periodically rats had cardiovascular
measurements of mean arterial pressure and heart rate as well as measurements
of renal sympathetic nerve activity. Rats were then sacrificed, and levels of
superoxide dismutase and NAPDH oxidase were measured in brain slices via
western blotting.
Results of
the study are as follows. 6 weeks after ovariectomy rats showed significant
increases in blood pressure, heart rate and renal sympathetic nerve activity,
this affect was completely prevented by the injection of estrogen for 4 weeks.
Levels of reactive oxygen species in the RVLM were assessed by fluorescent labeling
showed that there was significantly more reactive oxygen species in the RVLM in
the ovariectomy group that in the sham group and that this was reduced by estrogen
replacement. Ovariectomized rats showed a higher level of NADPH oxidase and a
lower level of superoxide dismutase as compared to the sham group. This effect
was attenuated by estrogen replacement. This was as expected due to the fact that
a higher ratio of NADPH oxidase: superoxide dismutase would align with a higher
level of reactive oxygen species. These data suggest that the estrogen
replacement in ovariectomized rats decreases the blood pressure and
sympathoexcitation and that the mechanism behind this may be from an estrogen
dependent reduction in oxidative stress in the RVLM via changes in protein expression.
I thought
that this paper was a good paper to blog this week because of where I would
like to go in the lab with the running data. I would like to see what the
effect of ovariectomy and estrogen replacement is on the voluntary wheel
running of rats and I would like to investigate the role that estrogen has in
modulating the activity of the RVLM.
- Ben
A Preliminary Study of the Effectiveness of an Allostatic, Closed-Loop, Acoustic Stimulation Neurotechnology in the Treatment of Athletes with Persisting Post-concussion Symptoms
By: Charles H. Tegeler*, Catherine L. Tegeler, Jared F. Cook, Sung W. Lee, Lee Gerdes, Hossam A. Shaltout, Christopher M. Miles and Sean L. Simpson. Sports Medicine - Open (2016) 2:39
Athletes are at risk to suffering brain injuries, more specifically concussions. Concussions are usually associated with symptoms that come after the injury occurs. These include physical, cognitive, and emotional symptoms. Ideal treatments for concussions are still unknown. One possible treatment method could be the improved support of the autonomic nervous system (ANS). Studies have been shown that mild traumatic brain injuries (mTBI) are associated with lower heart rate variability(HRV). Individuals with TBI have also been seen to have tachycardia, hypertension, tachypnea, and diaphoresis. Aim of this study was to evaluate the potential role of high-resolution, relational, resonance-based electroencephalic mirroring (HIRREM), a noninvasive, closed-loop, acoustic stimulation neurotechnology, as a means to support symptom reduction, improved autonomic function, and return to play among athletes with post-concussion symptoms (PPCS). HIRREM studies the brains electrical activity and appies algorithms to analyze oscillatory patterns.
Hypothesis was that the use of HIRREM by athletes with PPS would be associated with reduction in self reported symptom scores, improved autonomic cardiovascular regulation, and improved reaction testing.
16 athletes with PPC were used in this study and went through the different treatments with HIRREM. An initial screening is done and symptoms are reported by the students. They go through an initial HIRREM baseline assessment to scan for patterns and frequencies. Additional HIRREM sessions lasted for a mean of 29.6 days (SD 23.2). Symptoms were reported using the post-concussion symptoms questionnaire (RPQ), which is a 16 item survey that asses severity of concussions. Also used to assess the patients was the Insomnia Severity Index as well as the Center for Epidemiologic Studies Depression Scale. Blood pressure and heart rate was recorded pre-HIRREM and post HIRREM. Lastly, reaction testing was done to 7 participants that involved the drop-stick apparatus pre HIRREM and post HIRREM.
The results showed that total scores for all 3 self report measures and 14 of 16 individual items of the RPQ showed statistical improvements following HIRREM treatment. All measures of autonomic cardiovascular regulation increased. Distance on drop-stick reaction testing improved from 23.8cm to 19.8 following HIRREM. Following HIRREM, 15 students were able to return to full exercise and 10 were able to return to their sport.
We have seen that HIRREM is extremely effective in the treatment of athletes with post concussion symptoms. One thing that I did notice was that there was no control group. I am guessing this was intentional due to the fact that concussions need to be treated somehow. The study mentioned a worry about a placebo effect, due to the fact that the exposure of the study will cause a placebo response by the student athletes. This very well may be true. The study did lead to improved symptoms and improved autonomic cardiovascular regulation after the treatment of HIRREM.
-Tsetse Fly
Athletes are at risk to suffering brain injuries, more specifically concussions. Concussions are usually associated with symptoms that come after the injury occurs. These include physical, cognitive, and emotional symptoms. Ideal treatments for concussions are still unknown. One possible treatment method could be the improved support of the autonomic nervous system (ANS). Studies have been shown that mild traumatic brain injuries (mTBI) are associated with lower heart rate variability(HRV). Individuals with TBI have also been seen to have tachycardia, hypertension, tachypnea, and diaphoresis. Aim of this study was to evaluate the potential role of high-resolution, relational, resonance-based electroencephalic mirroring (HIRREM), a noninvasive, closed-loop, acoustic stimulation neurotechnology, as a means to support symptom reduction, improved autonomic function, and return to play among athletes with post-concussion symptoms (PPCS). HIRREM studies the brains electrical activity and appies algorithms to analyze oscillatory patterns.
Hypothesis was that the use of HIRREM by athletes with PPS would be associated with reduction in self reported symptom scores, improved autonomic cardiovascular regulation, and improved reaction testing.
16 athletes with PPC were used in this study and went through the different treatments with HIRREM. An initial screening is done and symptoms are reported by the students. They go through an initial HIRREM baseline assessment to scan for patterns and frequencies. Additional HIRREM sessions lasted for a mean of 29.6 days (SD 23.2). Symptoms were reported using the post-concussion symptoms questionnaire (RPQ), which is a 16 item survey that asses severity of concussions. Also used to assess the patients was the Insomnia Severity Index as well as the Center for Epidemiologic Studies Depression Scale. Blood pressure and heart rate was recorded pre-HIRREM and post HIRREM. Lastly, reaction testing was done to 7 participants that involved the drop-stick apparatus pre HIRREM and post HIRREM.
The results showed that total scores for all 3 self report measures and 14 of 16 individual items of the RPQ showed statistical improvements following HIRREM treatment. All measures of autonomic cardiovascular regulation increased. Distance on drop-stick reaction testing improved from 23.8cm to 19.8 following HIRREM. Following HIRREM, 15 students were able to return to full exercise and 10 were able to return to their sport.
We have seen that HIRREM is extremely effective in the treatment of athletes with post concussion symptoms. One thing that I did notice was that there was no control group. I am guessing this was intentional due to the fact that concussions need to be treated somehow. The study mentioned a worry about a placebo effect, due to the fact that the exposure of the study will cause a placebo response by the student athletes. This very well may be true. The study did lead to improved symptoms and improved autonomic cardiovascular regulation after the treatment of HIRREM.
-Tsetse Fly
Subscribe to:
Posts (Atom)